Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 194

Sort by

Sort Order Select

Journal Articles

Evaluation of Virus-Specific T Cell Responses in Patients Affected with Myeloproliferative Neoplasms Treated with Ruxolitinib

Elisa Rumi, MD, Chiara Cavalloni, MD, Giuditta Comolli, Virginia Valeria Ferretti, Irene Cassaniti, Daniela Pietra, PhD, Chiara Trotti, MD, Michele Ciboddo, MD, Melania Degli Antoni, Milena Furione, Fausto Baldanti, MD, Luca Arcaini, Mario Cazzola, MD

Blood (2019) 134 (Supplement_1): 1660.

https://doi.org/10.1182/blood-2019-127994

Published: 2019

Journal Articles

The Children's Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine Learning

Blood (2019) 134 (Supplement_1): 635.

https://doi.org/10.1182/blood-2019-126128

Published: 2019

Journal Articles

Results of PAC203: A Randomized Phase 2 Dose-Finding Study and Determination of the Recommended Dose of Pacritinib

Aaron T. Gerds, MD MS, Michael R. Savona, MD, Bart L. Scott, MD, Moshe Talpaz, MD, Miklos Egyed, Claire N Harrison, Professor, Abdulraheem Yacoub, MD, Alessandro M. Vannucchi, MD, Adam J. Mead, MD PhD, Jennifer O'Sullivan, Sarah A Buckley, MD, Diane R. Mould, PhD, Shanthakumar Tyavanagimatt, PhD, Jennifer A. Smith, PhD, John Mascarenhas, MD

Blood (2019) 134 (Supplement_1): 667.

https://doi.org/10.1182/blood-2019-129293

Published: 2019

Journal Articles

Clinical Features and Diagnostic Delay of Tuberculosis (TB) in Patients with Acute Myeloid Leukemia. (AML)

Veronica Bravo Villa, Hematology Fellow, Emmanuel Martínez Moreno, Hematology Fellow, Nidia Zapata, MD

Blood (2019) 134 (Supplement_1): 5114.

https://doi.org/10.1182/blood-2019-128158

Published: 2019

Journal Articles

Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan

Hsin-An Hou, Chien-Chin Lin, MD, Ming-Chung Kuo, MD, Shyuann-Yuh Lin, MD, Jyh-Pyng Gau, MD, Ming-Chung Wang, MD, Ming-Chih Chang, MD, Tsung-Chih Chen, MD, Su-Peng Yeh, MD, Yeu-Chin Chen, MD, Cih-En Huang, MD, Chieh-Wen Chen, MD, Yee-Ming Lee, PhD, Fan-Chen Ku, MD, Lee-Yung Shih, MD

Blood (2019) 134 (Supplement_1): 5374.

https://doi.org/10.1182/blood-2019-129645

Published: 2019

Journal Articles

A Phase 2, Randomized, Open-Label, 2-Arm Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) (TEMPO)

Reem Karmali, MD, Hagop Youssoufian, MD, Kam Sprott, PhD, David T. Weaver, PhD, Narayana Narasimhan, Stephanie Lustgarten, PhD, Gloria Patrick, Alena Zalutskaya, Leo I. Gordon, MD

Blood (2019) 134 (Supplement_1): 5251.

https://doi.org/10.1182/blood-2019-124406

Published: 2019

Journal Articles

Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) Registry

Blood (2019) 134 (Supplement_1): 4180.

https://doi.org/10.1182/blood-2019-125864

Published: 2019

Journal Articles

IMPACT-TB: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. Imatinib Mesylate per Oral As a Clinical Therapeutic for TB

Cynthia R. Giver, PhD, Pamela A Shaw, PhD, Helen Fletcher, PhD, Deepak Kaushal, PhD, Garcia Pamela, Deborah Omoyege, Gregory Bisson, MD, Tawanda Gumbo, MD, Robert Wallis, MD, Edmund K. Waller, PhDMD, Daniel Kalman, PhD

Blood (2019) 134 (Supplement_1): 1050.

https://doi.org/10.1182/blood-2019-130275

Published: 2019

Journal Articles

Haploidentical Stem Cell Transplantation with TCR Alpha/Beta and CD19 Depletion in Adult Patients with Hematological Malignancies

Maria V. Dovydenko, MD PhD, Elena N. Parovichnikova, MD PhD, Larisa A. Kuzmina, MD PhD, Vera A. Vasilyeva, MD PhD, Mikhail Yu. Drokov, MD PhD, Olga M. Koroleva, MD, Ekaterina D. Mikhaltsova, MD PhD, Natalia N. Popova, MD, Zoya V. Konova, Anna A. Dmitrova, MD, Ulyana V. Maslikova, MD, Olga S. Starikova, MD, Tatiana V. Gaponova, MD PhD, Denis V. Kamelskih, MD, Michael Maschan, MDMSc, Valeriy G. Savchenko, MD PhD

Blood (2019) 134 (Supplement_1): 5648.

https://doi.org/10.1182/blood-2019-131316

Published: 2019

Journal Articles

Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic Population

Christianne Bourlon, MD, Oscar Manuel Fierro-Angulo, MD, Jesus A Garcia-Ramos, MD, Rocio Camacho-Hernandez, MD, Roberta Demichelis, MD, Aldo A Acosta-Medina, MS

Blood (2019) 134 (Supplement_1): 3259.

https://doi.org/10.1182/blood-2019-131425

Published: 2019

Journal Articles

Outcome and Risk Factors of Transplantation-Associated Active Tuberculosis in Allogeneic Haematopoietic Stem Cell Transplantation: A Nested Case Control Study

Yanmin Zhao, MD, Apeng Yang, MD, Jimin Shi, MD, Yi Luo, MD, Xiaoyu Lai, PhD, Yamin Tan, MD, Jian Yu, MD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 3427.

https://doi.org/10.1182/blood-2018-99-119027

Published: 2018

Journal Articles

A Polymorphism in Toll-like Receptor 2 Gene Is Associated with Occurrence of Bacterial Infections in Sickle Cell Disease Patients

Blood (2018) 132 (Supplement 1): 3652.

https://doi.org/10.1182/blood-2018-99-112296

Published: 2018

Journal Articles

Baseline Characteristics of 3046 Non-Hodgkin's Lymphoma Patients Diagnosed between July 2015 and May 2018: A Report from China Lymphoma Patient Registry (CLAP)

Yuqin Song, MD PhD, Huilai Zhang, MD PhD, Haiyan Yang, PhD, Aichun Liu, MD, Xinan Cen, MD, Jun Zhu, MD PhD, Yi Wen, PhD

Blood (2018) 132 (Supplement 1): 5394.

https://doi.org/10.1182/blood-2018-99-112777

Published: 2018

Journal Articles

Stem Cell Regulation During Chronic Infection

Katherine Y. King, MD PhD

Blood (2018) 132 (Supplement 1): SCI-32.

https://doi.org/10.1182/blood-2018-99-109491

Published: 2018

Journal Articles

Non-Diffuse Large B-Cell Primary Central Nervous System Lymphoma

Sangeetha Gandhi, MBBS, Grzegorz S. Nowakowski, MD, Thomas M. Habermann, MD, Kay M. Ristow, BS, Patrick Johnston

Blood (2018) 132 (Supplement 1): 4208.

https://doi.org/10.1182/blood-2018-99-119741

Published: 2018

Journal Articles

Ruxolitinib Combined with Etanercept for Patients with Corticosteroid-Refractory Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation: A Multi-Center Prospective Study

Yanmin Zhao, MD, Jimin Shi, MD, Xiaoqing Li, Yi Luo, MD, Yamin Tan, MD, Xiaoyu Lai, PhD, Jian Yu, MD, Jianping Lan, PhD, Wanmao Ni, PhD, Lieguang Chen, MD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 4561.

https://doi.org/10.1182/blood-2018-99-118649

Published: 2018

Journal Articles

Baseline Characteristics of 412 Hodgkin's Lymphoma Patients Diagnosed between July 2015 and May 2018: A Report from China Lymphoma Patient Registry (CLAP)

Huilai Zhang, MD PhD, Yuqin Song, MD PhD, Aichun Liu, MD, Haiyan Yang, PhD, Xinan Cen, MD, Jun Zhu, MD PhD, Yi Wen, PhD

Blood (2018) 132 (Supplement 1): 5362.

https://doi.org/10.1182/blood-2018-99-112755

Published: 2018

Journal Articles

Lymphadenopathy in a TB-Endemic Region: Employing Focused Techniques in a Rapid Access Lymph Node Biopsy Clinic

Katherine Rae Antel, Estelle Verburgh, MD PhD, Vernon J. Louw, MD PhD, Jenna Oosthuizen, Francois Malherbe, Maartens Gary, Mark Nicol

Blood (2018) 132 (Supplement 1): 5318.

https://doi.org/10.1182/blood-2018-99-112794

Published: 2018

Journal Articles

Epidemiological Study of Aplastic Anemia in Algeria for 844 Cases over 10 Years (2007-2016)

Blood (2018) 132 (Supplement 1): 5109.

https://doi.org/10.1182/blood-2018-99-114094

Published: 2018

Journal Articles

Detection of a New NFKB1 Frameshift Mutation Associated with Primary Immunodeficiency Diseases

Anli Liu, Qi Feng, Shuwen Wang, Mingqiang Hua, Yu Hou, Xinyi Zuo, Ming Hou, MD PhD, Guoyu Meng, Jun Peng, MD PhD

Blood (2018) 132 (Supplement 1): 2416.

https://doi.org/10.1182/blood-2018-99-115723

Published: 2018

NARROW

Evaluation of Virus-Specific T Cell Responses in Patients Affected with Myeloproliferative Neoplasms Treated with Ruxolitinib

The Children's Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine Learning

Results of PAC203: A Randomized Phase 2 Dose-Finding Study and Determination of the Recommended Dose of Pacritinib

Clinical Features and Diagnostic Delay of Tuberculosis (TB) in Patients with Acute Myeloid Leukemia. (AML)

Interim Analysis of Registry of Ruxolitinib Treatment in Patients with Intermediate-2 or High Risk Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) in Taiwan

A Phase 2, Randomized, Open-Label, 2-Arm Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) (TEMPO)

Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) Registry

IMPACT-TB: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. Imatinib Mesylate per Oral As a Clinical Therapeutic for TB

Haploidentical Stem Cell Transplantation with TCR Alpha/Beta and CD19 Depletion in Adult Patients with Hematological Malignancies

Latent Tuberculosis in Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Strategies to Prevent Disease Activation in an Endemic Population

Outcome and Risk Factors of Transplantation-Associated Active Tuberculosis in Allogeneic Haematopoietic Stem Cell Transplantation: A Nested Case Control Study

A Polymorphism in Toll-like Receptor 2 Gene Is Associated with Occurrence of Bacterial Infections in Sickle Cell Disease Patients

Baseline Characteristics of 3046 Non-Hodgkin's Lymphoma Patients Diagnosed between July 2015 and May 2018: A Report from China Lymphoma Patient Registry (CLAP)

Stem Cell Regulation During Chronic Infection

Non-Diffuse Large B-Cell Primary Central Nervous System Lymphoma

Ruxolitinib Combined with Etanercept for Patients with Corticosteroid-Refractory Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation: A Multi-Center Prospective Study

Baseline Characteristics of 412 Hodgkin's Lymphoma Patients Diagnosed between July 2015 and May 2018: A Report from China Lymphoma Patient Registry (CLAP)

Lymphadenopathy in a TB-Endemic Region: Employing Focused Techniques in a Rapid Access Lymph Node Biopsy Clinic

Epidemiological Study of Aplastic Anemia in Algeria for 844 Cases over 10 Years (2007-2016)

Detection of a New NFKB1 Frameshift Mutation Associated with Primary Immunodeficiency Diseases

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only